Your browser doesn't support javascript.
loading
Glycosylated sphingolipids and progression to kidney dysfunction in type 1 diabetes.
Lopes-Virella, Maria F; Baker, Nathaniel L; Hunt, Kelly J; Hammad, Samar M; Arthur, John; Virella, Gabriel; Klein, Richard L.
Afiliação
  • Lopes-Virella MF; Division of Diabetes, Endocrinology and Medical Genetics, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA; Ralph H. Johnson VA Medical Center, Charleston, SC, USA. Electronic address: virellam@musc.edu.
  • Baker NL; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
  • Hunt KJ; Ralph H. Johnson VA Medical Center, Charleston, SC, USA; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
  • Hammad SM; Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, USA.
  • Arthur J; Division of Nephrology, Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Virella G; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA.
  • Klein RL; Division of Diabetes, Endocrinology and Medical Genetics, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA; Ralph H. Johnson VA Medical Center, Charleston, SC, USA.
J Clin Lipidol ; 13(3): 481-491.e1, 2019.
Article em En | MEDLINE | ID: mdl-31043336

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esfingolipídeos / Progressão da Doença / Diabetes Mellitus Tipo 1 / Rim Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esfingolipídeos / Progressão da Doença / Diabetes Mellitus Tipo 1 / Rim Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article